---
$id: https://graph.org.ai/products/commodity/51183407
$type: Product
source: UNSPSC
code: "51183407"
title: "Mitiglinide calcium hydrate"
class: "51183400"
classTitle: "Antidiabetic and hyperglycemic glinides"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitiglinide calcium hydrate

**UNSPSC Code**: 51183407
**Class**: [Antidiabetic and hyperglycemic glinides](Antidiabetic and hyperglycemic glinides.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent with the molecular formula 2C19H24NO3.Ca.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9651C21W3Z, chemically known as bis((2s)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionate) calcium dihydrate, d-, but more generally known as mitiglinide calcium hydrate, which bears US NIH Compound Identifier 6918235. European Medicines Agency schedules mitiglinide calcium hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08999MIG. Most nations, for tariff purposes, schedule mitiglinide calcium hydrate under HS 29339990. SMILES: C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].O.O.[CA+2].

